Swiss Market Index

Swiss Market Index
Name	Swiss Market Index
Acronym	SMI
Introduced	1988
Operator	SIX Swiss Exchange
Constituents	20 blue-chip companies
Cap level	Large-cap
Base value	1000
Base date	1988-06-30
Currency	Swiss franc (CHF)

Swiss Market Index is Switzerland's principal stock index tracking 20 large-cap companies listed on the SIX Swiss Exchange. It serves as a benchmark for institutional investors, pension funds, and retail investors, reflecting performance of major Swiss corporations across sectors including finance, pharmaceuticals, consumer goods, and industrials. The index is widely used in derivatives markets, exchange-traded funds, and passive investment strategies.

History

The index was established in 1988 by the SIX Swiss Exchange, evolving from market measures used by the Zurich stock marketplace during the 1970s and 1980s. Early market participants included banks such as UBS Group AG, Credit Suisse Group AG, and industrial conglomerates like Nestlé S.A. and Novartis AG. During the 1990s the rise of technology companies globally influenced Swiss listings, while corporate actions by Roche Holding AG and mergers such as Glencore plc acquisitions altered market composition. The 2000s saw regulatory changes following events involving Swissair, which impacted Swiss capital markets and led to reforms affecting listing rules administered by SIX. The global financial crisis of 2007–2008 involved major SMI constituents including Julius Baer Group and international counterparties such as Deutsche Bank AG and Goldman Sachs. In the 2010s, reforms from organizations like the International Organization of Securities Commissions and initiatives linked to European Union financial directives influenced disclosure standards for SMI companies such as Credit Suisse Group AG and UBS Group AG. More recent decades included corporate restructurings from firms like ABB Ltd, acquisition activity by Bayer AG and Takeda Pharmaceutical Company Limited, and growing ETF issuance by providers such as BlackRock, Inc. and Vanguard Group tied to the index.

Composition and Constituents

The index comprises 20 of the largest and most liquid Swiss-listed companies on the SIX Swiss Exchange, representing sectors led by pharmaceutical firms like Roche Holding AG and Novartis AG, banking institutions such as UBS Group AG and Credit Suisse Group AG, consumer companies including Nestlé S.A. and Lindt & Sprüngli AG, and industrials exemplified by ABB Ltd and Georg Fischer AG. Constituents have ranged over time to include commodity and trading houses such as Glencore plc and Trafigura Group Pte Ltd listings, insurance firms like Zurich Insurance Group AG and Swiss Re AG, and luxury goods companies such as Richemont and Swatch Group AG. The index excludes smaller-cap and mid-cap firms typically found on the SIX Swiss Exchange SME segment and is periodically reviewed with eligibility rules referencing free-float thresholds and liquidity metrics applied to issuers like Lonza Group AG and SGS SA. Weighting changes can be driven by corporate events involving entities such as Cie Financière Richemont SA or spin-offs from conglomerates like Clariant AG.

Calculation Methodology

The SMI is calculated as a free-float, market-capitalization-weighted price index denominated in Swiss franc (CHF), with returns published on a real-time basis by the SIX Swiss Exchange. Calculation rules account for corporate actions such as dividends, share splits, mergers, and rights issues, following standards similar to methodologies from FTSE Russell and MSCI Inc. to ensure investability for passive vehicles from firms like iShares and Vanguard. Index governance entails periodic reviews using liquidity measures derived from trading data provided by market participants including SIX Group AG members and authorized data vendors such as Bloomberg L.P. and Refinitiv. Adjustments for free-float and capping rules are applied to limit concentration risk from dominant companies such as Roche Holding AG and Novartis AG.

Market Capitalization and Weighting

Constituents are weighted by free-float market capitalization, which results in heavyweight positions for multi-billion franc corporations like Nestlé S.A., Novartis AG, Roche Holding AG, and major banks UBS Group AG and Credit Suisse Group AG when included. To prevent single-name dominance, the index methodology employs capping mechanisms similar to those used by S&P Dow Jones Indices and NASDAQ OMX Group indices. Market capitalization exposure affects index-linked products issued by firms such as iShares, UBS Asset Management, and Credit Suisse Asset Management. The aggregate market cap tracked by the index is a significant share of total market capitalization listed on the SIX Swiss Exchange.

Performance and Historical Returns

Historically, the index has reflected strong returns driven by the global competitiveness of Swiss pharmaceuticals, consumer brands, and financial services. Long-term performance comparisons reference international benchmarks like MSCI World Index, S&P 500, and Euro Stoxx 50. Episodes of volatility corresponded with global events including the Dot-com bubble, the 2007–2008 financial crisis, the European sovereign debt crisis, and macro shocks tied to central bank actions from the Swiss National Bank and the European Central Bank. Performance has also been affected by currency moves of the Swiss franc against the US dollar and Euro, corporate earnings announcements from Novartis AG and Roche Holding AG, and acquisition activity by multinationals such as Bayer AG.

Regulation and Governance

The index is administered by the SIX Swiss Exchange and governed under rules consistent with oversight from the Swiss Financial Market Supervisory Authority (FINMA) and broader international standards from organizations such as the International Organization of Securities Commissions (IOSCO). Listing eligibility, disclosure, and reporting obligations for constituents intersect with statutes like Swiss listing rules and regulatory frameworks influenced by cross-border agreements with the European Union and multilateral treaty obligations. Audit and financial reporting of index constituents involve accounting standards such as International Financial Reporting Standards (IFRS) used by companies like Richemont and UBS Group AG, and external auditors from firms including PricewaterhouseCoopers, KPMG, Deloitte, and Ernst & Young.

Influence and Economic Impact

The index is central to Switzerland's capital markets infrastructure, influencing asset allocation decisions of institutional investors such as the Swiss Federal Pension Fund, sovereign wealth entities, and global asset managers including BlackRock, Inc. and Vanguard Group. SMI-linked derivatives and ETFs impact liquidity and price discovery on the SIX Swiss Exchange and affect corporate access to capital for issuers like Nestlé S.A. and Novartis AG. Macro policy considerations by the Swiss National Bank and fiscal interactions with federal authorities in Bern reflect the systemic importance of SMI constituents to employment and trade with partners such as Germany, France, United States, China, and United Kingdom. The index also underpins philanthropic endowments and university investment portfolios at institutions like ETH Zurich and University of Zurich.

Category:Stock market indices